Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine for timing of urination in oliguric acute kidney failure
IRCT2017011513366N6Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of dopamine in acute kidney failure (AKF) and oliguria, sponsored by Arak University of Medical Sciences. Primary endpoint: Timing of urination. Started Oct 2016; status: completed.
02
Drugs
dopamine
03
Conditions
acute kidney failure (AKF)oliguria
Beyond the preview
Go deeper on IRCT2017011513366N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017011513366N6.